Naltrexone Completed Phase 3 Trials for BMI >27 kg/m2 / Type 2 Diabetes Mellitus / BMI >30 kg/m2 Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00474630A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes
NCT00456521A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program
NCT00532779A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects
NCT00567255A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects